David Malcolm Crowe
12Patents
6h-index
31Co-inventors
66Inventor score
Filing activity: Feb 4, 2002 → Dec 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10696668B2 | Acid addition salts of piperazine derivatives | Chemistry; Metallurgy | 12 | Active |
| US8227477B2 | Nilotinib HCl crystalline forms | Human Necessities | 11 | Active |
| US7592329B2 | Crystalline complexes of fluticasone-2-furoate | Chemistry; Metallurgy | 10 | Expired |
| US8592442B2 | Nilotinib HCl crystalline forms | Human Necessities | 10 | Active |
| US6777399B2 | Anti-inflammatory androstane derivative compositions | Chemistry; Metallurgy | 9 | Expired |
| US11591327B2 | Acid addition salts of piperazine derivatives | Chemistry; Metallurgy | 6 | Active |
| US10752607B2 | Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors | Chemistry; Metallurgy | 4 | Active |
| US11230537B2 | Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12195455B2 | Succinate and fumarate acid addition salts of piperazine derivatives | Chemistry; Metallurgy | 1 | Active |
| US11739068B2 | Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof | Chemistry; Metallurgy | 0 | Active |
| US12398130B2 | Acid addition salts of piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11584735B2 | Solid forms of a plasma kallikrein inhibitor and salts thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.